ASND earnings date and history (2026)
Ascendis Pharma A/S Ordinary Share (ASND) next reports earnings on Wed Nov 11. Analysts expect EPS of $1.13 (8 estimates), against -$1.17 in the same quarter a year ago. Last time, on Thu Aug 13, it reported $3.29 against a $0.78 consensus (+321.8%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 13, 2026 | $0.78 | $3.29 | — |
| Aug 6, 2026 | — | — | — |
| May 7, 2026 | $0.21 | $0.32 | — |
| Feb 11, 2026 | -$0.06 | -$0.64 | — |
| Nov 12, 2025 | -$0.41 | -$1.17 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does ASND report earnings?
- ASND is scheduled to report on Wed Nov 11, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from ASND?
- The consensus estimate is $1.13 a share across 8 analysts; the same quarter a year ago came in at -$1.17.
- Did ASND beat earnings last quarter?
- Yes: on Thu Aug 13 ASND reported $3.29 against a $0.78 consensus, a +321.8% surprise.